Search Results - "Leist, Sarah R."

PubPharm (138)

1

Animal models of Long Covid : A hit-and-run disease

in: Science translational medicine | 2024

by Schäfer, A. | Leist, S. | Powers, J. | +1

2

Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East Respiratory Syndrome coronavirus disease severity

in: bioRxiv.org | 2024

by Sims, A. | Schäfer, A. | Okuda, K. | +17

3

Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19

in: bioRxiv.org | 2024

by Boon, A. | L. Bricker, T. | Fritch, E. | +7

4

Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination

in: Cell reports. Medicine | 2024

by Voss, W. | Mallory, M. | Byrne, P. | +22

UpdateOf: bioRxiv. 2024 Jan 23:2024.01.22.576742. doi: 10.1101/2024.01.22.576742. - PMID 38545622

5

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

in: bioRxiv.org | 2024

by Martinez, D. | Schaefer, A. | Leist, S. | +12

6

Chimeric spike mRNA vaccines protect against Sarbecoviruschallenge in mice

in: bioRxiv.org | 2024

by Martinez, D. | Schäfer, A. | Leist, S. | +14

7

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

in: bioRxiv.org | 2024

by Sun, W. | Leist, S. | McCroskery, S. | +10

8

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection

in: bioRxiv.org | 2024

by Graham, J. | Swarts, J. | Leist, S. | +12

9

SARS-CoV-2 D614G Variant Exhibits Enhanced Replicationex vivoand Earlier Transmissionin vivo

in: bioRxiv.org | 2024

by Hou, Y. | Chiba, S. | Halfmann, P. | +17

10

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus

in: bioRxiv.org | 2024

by Sheahan, T. | Sims, A. | Zhou, S. | +21

1
2
3
4
5
6
7
8
9
10
11
Next »
[14]